Family Medicine · Akron, OH
NPI
1386725125
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1569 Vernon Odom Blvd
Akron, OH, 44320
Phone (330) 867-7544
Groups this clinician bills Medicare through
Medicare paid, 2024
$118K
1,506 services
Medicare patients, 2024
261
Average age 73
Drug cost, 2024
$3.1M
34,894 prescriptions
Company payments, 2025
$6,931
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benson S Bonyo was code 99309 (snf e&m), 765 times for 138 patients. In total Benson S Bonyo billed 1,506 services in 35 codes, and Medicare paid $118K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Office | 765 | 138 | $79.76 | $61K |
| 99306 SNF E&M | Facility | 143 | 113 | $137.42 | $20K |
| 99214 Office E&M - Established | Office | 130 | 51 | $86.31 | $11K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 74 | 11 | $47.23 | $3,495 |
| 99308 SNF E&M | Facility | 68 | 42 | $56.04 | $3,810 |
| 99213 Office E&M - Established | Office | 62 | 38 | $54.30 | $3,367 |
| 82962 Clinical Chemistry | Office | 42 | 20 | $3.21 | $135 |
| 99310 SNF E&M | Facility | 38 | 32 | $115.93 | $4,405 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 21 | 21 | $155.81 | $3,272 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 11 | 11 | $121.38 | $1,335 |
By year: 2022 $91K for 1,451 services; 2023 $94K for 1,247 services; 2024 $118K for 1,506 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 42 | 20 | $3.21 | $135 |
Medicare prescription drug claims, 2024
In 2024, the drug Benson S Bonyo prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,748 prescriptions and refills. In total Benson S Bonyo wrote 34,894 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,748 | 2,181 | 312 | $25K |
| Amlodipine Besylate Generic | 1,362 | 2,055 | 273 | $13K |
| Eliquis Apixaban | 923 | 947 | 127 | $384K |
| Gabapentin Generic | 920 | 987 | 150 | $18K |
| Pantoprazole Sodium Generic | 814 | 936 | 149 | $19K |
| Levothyroxine Sodium Generic | 759 | 885 | 120 | $9,877 |
| Furosemide Generic | 729 | 814 | 148 | $5,317 |
| Potassium Chloride Generic | 656 | 734 | 105 | $14K |
| Omeprazole Generic | 618 | 845 | 111 | $11K |
| Trazodone Hcl Generic | 604 | 623 | 106 | $8,511 |
| Lisinopril Generic | 601 | 829 | 109 | $6,401 |
| Metformin Hcl Generic | 572 | 720 | 99 | $6,890 |
| Metoprolol Tartrate Generic | 538 | 629 | 98 | $5,852 |
| Mirtazapine Generic | 507 | 555 | 97 | $13K |
| Sertraline Hcl Generic | 489 | 499 | 75 | $6,828 |
Brand drugs: 5,177 claims; generic drugs: 29,542 claims; opioid claims: 830.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benson S Bonyo $6,931 ($6,931 in general payments such as food, travel and fees) from 33 companies. The largest payer was Phathom Pharmaceuticals, Inc. with $3,913.
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. PHAT | 9 | $3,913 |
| Corcept Therapeutics CORT | 8 | $244 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $196 |
| Novo Nordisk Inc NVO | 7 | $194 |
| Lilly USA, LLC LLY | 15 | $168 |
| Abbvie Inc. ABBV | 17 | $165 |
| Pfizer Inc. PFE | 10 | $161 |
| Exact Sciences Corporation EXAS | 9 | $158 |
| Xeris Pharmaceuticals, Inc. | 10 | $151 |
| Kowa Pharmaceuticals America, Inc. | 3 | $146 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.